Barclays’s CVRx CVRX Stock Holding History

Barclays’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-35,800	Closed	-$1.13M	–	5133
2023 Q4	$1.13M	Buy	+35,800	New	+$672K	﹤0.01%	3350

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GSK plc London $599M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's CVRX Position: Q1 2026 in Review

Barclays reduced its CVRx (CVRX) stake by 88% in Q1 2026, selling an estimated $163K and leaving 3,003 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4497.

Barclays first reported a position in CVRX in Q1 2022 and has held it in 14 quarters since. The position peaked at $528K in Q1 2023. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

Barclays held 3,003 shares of CVRx worth $28.4K as of Q1 2026.
Barclays sold 22,259 CVRx shares in Q1 2026, an estimated $163K.
CVRx made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4497 holding.
Barclays first reported a position in CVRx in Q1 2022 and has held it in 14 quarters since.
Barclays's CVRx position peaked at $528K in Q1 2023.
99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.